Literature DB >> 18547097

Characterization of the tetratricopeptide-containing domain of BUB1, BUBR1, and PP5 proves that domain amphiphilicity over amino acid sequence specificity governs protein adsorption and interfacial activity.

Sylvie Beaufils1, J Günter Grossmann, Anne Renault, Victor M Bolanos-Garcia.   

Abstract

The tetratricopeptide motif repeat (TPR) is an alpha-helix-turn-alpha-helix motif that typically mediates protein-protein and, in some cases, protein-lipid interactions. Because of its success, this motif has been preserved through evolution and can be identified in proteins of a wide range of functions in lower and higher organisms. The N-terminal region of BUB1, BUBR1, and protein phosphatase 5 (PP5) contains tandem arrangements of the TPR motif. BUB1 and BUBR1 are conserved multidomain protein kinases that play a key role in the mitotic checkpoint, the mechanism that ensures the synchrony of chromosome segregation. PP5 is an enzyme that targets a wide range of protein substrates including single transmembrane receptors and mammalian cryptochromes. The N-terminal TPR domain of PP5 regulates the activity of the C-terminal catalytic domain through direct interaction with protein and lipid molecules. We portray the biophysical and biochemical properties of the tandem arrangements of the TPR motif of BUB1, BUBR1, and PP5 using far-UV spectroscopy, solution X-ray scattering, null ellipsometry, surface rheology measurements, and Brewster angle microscopy (BAM) observations. We show that, despite the low amino acid sequence conservation and different function, the TPR motif repeats of the three proteins exhibit similar interfacial properties including adsorption kinetics, high surface activity, and the formation of stable, rigid films at the air/water interface. Our studies demonstrate that domain amphiphilicity is of higher importance than amino acid sequence specificity in the determination of protein adsorption and interfacial activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18547097     DOI: 10.1021/jp711222s

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  6 in total

1.  Characterization of spindle checkpoint kinase Mps1 reveals domain with functional and structural similarities to tetratricopeptide repeat motifs of Bub1 and BubR1 checkpoint kinases.

Authors:  Semin Lee; Philippe Thebault; Luca Freschi; Sylvie Beaufils; Tom L Blundell; Christian R Landry; Victor M Bolanos-Garcia; Sabine Elowe
Journal:  J Biol Chem       Date:  2011-12-20       Impact factor: 5.157

Review 2.  Leader of the SAC: molecular mechanisms of Mps1/TTK regulation in mitosis.

Authors:  Spyridon T Pachis; Geert J P L Kops
Journal:  Open Biol       Date:  2018-08       Impact factor: 6.411

Review 3.  Physiological relevance of post-translational regulation of the spindle assembly checkpoint protein BubR1.

Authors:  Celia R Bloom; Brian J North
Journal:  Cell Biosci       Date:  2021-04-23       Impact factor: 7.133

4.  The crystal structure of the N-terminal region of BUB1 provides insight into the mechanism of BUB1 recruitment to kinetochores.

Authors:  Victor M Bolanos-Garcia; Tomomi Kiyomitsu; Sheena D'Arcy; Dimitri Y Chirgadze; J Günter Grossmann; Dijana Matak-Vinkovic; Ashok R Venkitaraman; Mitsuhiro Yanagida; Carol V Robinson; Tom L Blundell
Journal:  Structure       Date:  2009-01-14       Impact factor: 5.006

5.  A TPR domain-containing N-terminal module of MPS1 is required for its kinetochore localization by Aurora B.

Authors:  Wilco Nijenhuis; Eleonore von Castelmur; Dene Littler; Valeria De Marco; Eelco Tromer; Mathijs Vleugel; Maria H J van Osch; Berend Snel; Anastassis Perrakis; Geert J P L Kops
Journal:  J Cell Biol       Date:  2013-04-08       Impact factor: 10.539

6.  TGFBR2 mediated phosphorylation of BUB1 at Ser-318 is required for transforming growth factor-β signaling.

Authors:  Shyam Nyati; Brandon S Gregg; Jiaqi Xu; Grant Young; Lauren Kimmel; Mukesh K Nyati; Dipankar Ray; Corey Speers; Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2020-03-03       Impact factor: 5.715

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.